| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $175.6M | — | +9.8% |
| Cost of Revenue | $30.0M | — | +3.7% |
| Gross Profit | $145.6M | — | +11.2% |
| R&D Expense | $29.0M | — | -0.5% |
| SG&A Expense | $17.0M | — | -2.4% |
| Operating Income | $60.9M | — | +17.6% |
| Pre-tax Income | $65.0M | — | +11.5% |
| Income Tax | $14.3M | — | +33.2% |
| Net Income | $50.6M | — | +6.5% |
| EPS (Basic) | $1.42 | — | +9.2% |
| EPS (Diluted) | $1.42 | — | +10.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $279.5M | +11.7% | -3.9% |
| Accounts Receivable | $134.9M | -21.1% | +11.0% |
| Current Assets | $656.6M | -0.2% | +9.1% |
| Total Assets | $1.09B | -0.0% | +9.9% |
| Current Liabilities | $459.2M | -1.8% | +6.3% |
| Total Liabilities | $524.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $95.3M | — | -13.0% |
| Capital Expenditures | $1.7M | — | -18.2% |
| Investing Cash Flow | -$6.4M | — | +9.3% |
| Financing Cash Flow | -$59.7M | — | -35.5% |
| Free Cash Flow | $93.6M | — | -12.9% |
| +5.3% |
| Stockholders' Equity | $569.9M | +1.6% | +14.4% |